Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1899 1
1947 1
1948 8
1949 9
1950 3
1951 6
1952 11
1953 7
1954 1
1955 1
1956 1
1958 2
1960 1
1961 2
1962 2
1963 2
1964 4
1965 5
1966 10
1967 3
1968 7
1969 9
1970 11
1971 17
1972 9
1973 7
1974 9
1975 10
1976 13
1977 7
1978 7
1979 13
1980 9
1981 8
1982 8
1983 12
1984 18
1985 21
1986 14
1987 12
1988 15
1989 26
1990 26
1991 41
1992 29
1993 29
1994 44
1995 55
1996 51
1997 33
1998 29
1999 33
2000 20
2001 29
2002 21
2003 27
2004 33
2005 37
2006 49
2007 57
2008 58
2009 48
2010 52
2011 53
2012 70
2013 58
2014 61
2015 46
2016 37
2017 46
2018 54
2019 39
2020 41
2021 48
2022 60
2023 49
2024 51
2025 31

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,744 results

Results by year

Filters applied: . Clear all
Page 1
Obinutuzumab for the First-Line Treatment of Follicular Lymphoma.
Marcus R, Davies A, Ando K, Klapper W, Opat S, Owen C, Phillips E, Sangha R, Schlag R, Seymour JF, Townsend W, Trněný M, Wenger M, Fingerle-Rowson G, Rufibach K, Moore T, Herold M, Hiddemann W. Marcus R, et al. N Engl J Med. 2017 Oct 5;377(14):1331-1344. doi: 10.1056/NEJMoa1614598. N Engl J Med. 2017. PMID: 28976863 Free article. Clinical Trial.
The MAGNOLIA Trial: Zanubrutinib, a Next-Generation Bruton Tyrosine Kinase Inhibitor, Demonstrates Safety and Efficacy in Relapsed/Refractory Marginal Zone Lymphoma.
Opat S, Tedeschi A, Linton K, McKay P, Hu B, Chan H, Jin J, Sobieraj-Teague M, Zinzani PL, Coleman M, Thieblemont C, Browett P, Ke X, Sun M, Marcus R, Portell CA, Ardeshna K, Bijou F, Walker P, Hawkes EA, Mapp S, Ho SJ, Talaulikar D, Zhou KS, Co M, Li X, Zhou W, Cappellini M, Tankersley C, Huang J, Trotman J. Opat S, et al. Among authors: marcus r. Clin Cancer Res. 2021 Dec 1;27(23):6323-6332. doi: 10.1158/1078-0432.CCR-21-1704. Epub 2021 Sep 15. Clin Cancer Res. 2021. PMID: 34526366 Free PMC article.
2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative.
Dasgupta B, Cimmino MA, Maradit-Kremers H, Schmidt WA, Schirmer M, Salvarani C, Bachta A, Dejaco C, Duftner C, Jensen HS, Duhaut P, Poór G, Kaposi NP, Mandl P, Balint PV, Schmidt Z, Iagnocco A, Nannini C, Cantini F, Macchioni P, Pipitone N, Amo MD, Espígol-Frigolé G, Cid MC, Martínez-Taboada VM, Nordborg E, Direskeneli H, Aydin SZ, Ahmed K, Hazleman B, Silverman B, Pease C, Wakefield RJ, Luqmani R, Abril A, Michet CJ, Marcus R, Gonter NJ, Maz M, Carter RE, Crowson CS, Matteson EL. Dasgupta B, et al. Among authors: marcus r. Ann Rheum Dis. 2012 Apr;71(4):484-92. doi: 10.1136/annrheumdis-2011-200329. Ann Rheum Dis. 2012. PMID: 22388996 Free PMC article.
Disuse-induced muscle fibrosis, cellular senescence, and senescence-associated secretory phenotype in older adults are alleviated during re-ambulation with metformin pre-treatment.
Petrocelli JJ, McKenzie AI, de Hart NMMP, Reidy PT, Mahmassani ZS, Keeble AR, Kaput KL, Wahl MP, Rondina MT, Marcus RL, Welt CK, Holland WL, Funai K, Fry CS, Drummond MJ. Petrocelli JJ, et al. Among authors: marcus rl. Aging Cell. 2023 Nov;22(11):e13936. doi: 10.1111/acel.13936. Epub 2023 Jul 24. Aging Cell. 2023. PMID: 37486024 Free PMC article. Clinical Trial.
Reflections on electron transfer theory.
Marcus RA. Marcus RA. J Chem Phys. 2020 Dec 7;153(21):210401. doi: 10.1063/5.0035434. J Chem Phys. 2020. PMID: 33291931 No abstract available.
Peak bone mass.
Heaney RP, Abrams S, Dawson-Hughes B, Looker A, Marcus R, Matkovic V, Weaver C. Heaney RP, et al. Among authors: marcus r. Osteoporos Int. 2000;11(12):985-1009. doi: 10.1007/s001980070020. Osteoporos Int. 2000. PMID: 11256898 Review. No abstract available.
What Is Myasthenia Gravis?
Marcus R. Marcus R. JAMA. 2024 Feb 6;331(5):452. doi: 10.1001/jama.2023.16872. JAMA. 2024. PMID: 38153702
WHF IASC Roadmap on Chagas Disease.
Echeverría LE, Marcus R, Novick G, Sosa-Estani S, Ralston K, Zaidel EJ, Forsyth C, RIbeiro ALP, Mendoza I, Falconi ML, Mitelman J, Morillo CA, Pereiro AC, Pinazo MJ, Salvatella R, Martinez F, Perel P, Liprandi ÁS, Piñeiro DJ, Molina GR. Echeverría LE, et al. Among authors: marcus r. Glob Heart. 2020 Mar 30;15(1):26. doi: 10.5334/gh.484. Glob Heart. 2020. PMID: 32489799 Free PMC article. Review.
Combining Exercise Training and Testosterone Therapy in Older Women After Hip Fracture: The STEP-HI Randomized Clinical Trial.
Binder EF, Bartley JM, Berry SD, Doré PM, Fisher SR, Fortinsky RH, Guild C, Kiel DP, Kuchel GA, Marcus RL, McDonough CM, Monroe KM, Orwig DL, Paluch RA, Reeds D, Stevens-Lapsley J, Volpi E, Schechtman KB, Magaziner JS. Binder EF, et al. Among authors: marcus rl. JAMA Netw Open. 2025 May 1;8(5):e2510512. doi: 10.1001/jamanetworkopen.2025.10512. JAMA Netw Open. 2025. PMID: 40372752 Free PMC article. Clinical Trial.
1,744 results